InvestorsHub Logo
Followers 36
Posts 5775
Boards Moderated 0
Alias Born 02/20/2015

Re: None

Thursday, 05/17/2018 6:49:56 AM

Thursday, May 17, 2018 6:49:56 AM

Post# of 50157
FAAAADAAAAAAAH!

BOOV LIKES NEWS OF YESTERDAY SO BOOV BOUGHT MORES. DCTH IS BEST AND ONLY WITH CLINICAL TRIAL SUPPORTING EVIDENCE.

ALL WILL BE GREENS, ESPECIALLY THE DAYS OF FRIDAY!


The GGPO’s update was based on its evaluation of published data on treatment with CHEMOSAT as a loco-regional treatment for melanoma liver metastases. Following this evaluation, and after soliciting additional feedback from the oncology community in Germany, treatment with CHEMOSAT was classified with Evidence Level 1B, indicating the second highest level of evidence. Treatment with CHEMOSAT is the sole therapy classified with this top designation. Other loco-regional therapies previously included in the guidelines have been designated with Evidence Level 4, indicating an absence of clinical trial supporting evidence.

BOOV HOPES SURPRISES HAPPEN SOONS WITH ALL FOUR FINGERS CROSSED...


http://delcath.com/investors-news/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News